Loading stock data…
Zimmer Biomet Holdings, Inc. (ZBH)
$91.35+1.70 (+1.90%)
Market ClosedLast close Jul 24
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Zimmer Biomet Holdings, Inc. in the Healthcare sector is trading at $91.35 with a market capitalization of $16.4B. Wall Street consensus targets $98.60 (20 analysts), implying a +7.9% move over the next 12 months. The stock is currently 16% below its 52-week high of $108.29, remaining 0.7% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +7.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.09B↓ | $2.24B↑ | $2.00B↓ | $2.08B↑ | $1.91B |
| Gross Profit | $1.51B↑ | $1.45B↑ | $1.44B↓ | $1.49B↑ | $1.36B |
| Operating Income | $395.10M↑ | $282.60M↓ | $338.30M↓ | $396.40M↑ | $338.90M |
| Net Income | $238.10M↑ | $139.30M↓ | $230.90M↑ | $152.80M↓ | $182.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, inclu...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$16.44B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.02
Beta
Defensive asset. Lower volatility than the S&P 500.
0.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.05%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.01%
Volume
Today's trading volume
973,839
Recent News
Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?
The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.
Earnings Preview: What To Expect From Zimmer Biomet’s Report
Here’s what analysts are expecting out of Zimmer Biomet’s upcoming Q2 earnings report.
ISRG Stock: The Math Hidden In Its Price
At $353, Intuitive Surgical (ISRG) is being priced to deliver 14.1% revenue growth annually for the next 4 years simply to defend today's 42.1x multiple. That sits below the 21% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.
The Robot Maker's Paradox
You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.
What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?
The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.